Avidity Partners Management LP Arvinas, Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 1,358,000 shares of ARVN stock, worth $24.8 Million. This represents 2.94% of its overall portfolio holdings.
Number of Shares
1,358,000
Previous 1,497,000
9.29%
Holding current value
$24.8 Million
Previous $36.9 Million
29.4%
% of portfolio
2.94%
Previous 2.26%
Shares
19 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
70.9MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$129 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$123 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$114 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$75 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$61 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $973M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...